Nanotherapeutics, Inc. - Product Pipeline Review - 2016

  • ID: 3774222
  • Company Profile
  • 49 pages
  • Global Markets Direct
  • Nanotherapeutics
1 of 4
Nanotherapeutics, Inc. - Product Pipeline Review - 2016

Summary

‘Nanotherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Nanotherapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Nanotherapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Nanotherapeutics, Inc.
- The report provides overview of Nanotherapeutics, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Nanotherapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Nanotherapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Nanotherapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Nanotherapeutics, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Nanotherapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Nanotherapeutics, Inc. Snapshot

Nanotherapeutics, Inc. Overview

Key Information

Key Facts

Nanotherapeutics, Inc. - Research and Development Overview

Key Therapeutic Areas

Nanotherapeutics, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Nanotherapeutics, Inc. - Pipeline Products Glance

Nanotherapeutics, Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Nanotherapeutics, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Nanotherapeutics, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Nanotherapeutics, Inc. - Drug Profiles

influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine

Product Description

Mechanism of Action

R&D Progress

ross river virus vaccine

Product Description

Mechanism of Action

R&D Progress

(buprenorphine hydrochloride + naloxone hydrochloride)

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H9N2] vaccine

Product Description

Mechanism of Action

R&D Progress

NTC-942

Product Description

Mechanism of Action

R&D Progress

NTO-1151

Product Description

Mechanism of Action

R&D Progress

ramoplanin

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H5N1] vaccine

Product Description

Mechanism of Action

R&D Progress

West Nile virus vaccine

Product Description

Mechanism of Action

R&D Progress

XOMA-3AB

Product Description

Mechanism of Action

R&D Progress

chikungunya vaccine

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H7N9] vaccine

Product Description

Mechanism of Action

R&D Progress

middle east respiratory syndrome vaccine + severe acute respiratory syndrome vaccine

Product Description

Mechanism of Action

R&D Progress

norovirus (bivalent) virus like particle vaccine

Product Description

Mechanism of Action

R&D Progress

Rotavirus vaccine

Product Description

Mechanism of Action

R&D Progress

typhoid vaccine

Product Description

Mechanism of Action

R&D Progress

Nanotherapeutics, Inc. - Pipeline Analysis

Nanotherapeutics, Inc. - Pipeline Products by Target

Nanotherapeutics, Inc. - Pipeline Products by Route of Administration

Nanotherapeutics, Inc. - Pipeline Products by Molecule Type

Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action

Nanotherapeutics, Inc. - Recent Pipeline Updates

Nanotherapeutics, Inc. - Dormant Projects

Nanotherapeutics, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Nanotherapeutics, Inc., Key Information

Nanotherapeutics, Inc., Key Facts

Nanotherapeutics, Inc. - Pipeline by Indication, 2016

Nanotherapeutics, Inc. - Pipeline by Stage of Development, 2016

Nanotherapeutics, Inc. - Monotherapy Products in Pipeline, 2016

Nanotherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016

Nanotherapeutics, Inc. - Partnered Products in Pipeline, 2016

Nanotherapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Nanotherapeutics, Inc. - Pre-Registration, 2016

Nanotherapeutics, Inc. - Phase III, 2016

Nanotherapeutics, Inc. - Phase II, 2016

Nanotherapeutics, Inc. - Phase I, 2016

Nanotherapeutics, Inc. - Preclinical, 2016

Nanotherapeutics, Inc. - Pipeline by Target, 2016

Nanotherapeutics, Inc. - Pipeline by Route of Administration, 2016

Nanotherapeutics, Inc. - Pipeline by Molecule Type, 2016

Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016

Nanotherapeutics, Inc. - Recent Pipeline Updates, 2016

Nanotherapeutics, Inc. - Dormant Developmental Projects,2016

Nanotherapeutics, Inc., Other Locations

List of Figures

Nanotherapeutics, Inc. - Pipeline by Top 10 Indication, 2016

Nanotherapeutics, Inc. - Pipeline by Stage of Development, 2016

Nanotherapeutics, Inc. - Monotherapy Products in Pipeline, 2016

Nanotherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016

Nanotherapeutics, Inc. - Pipeline by Target, 2016

Nanotherapeutics, Inc. - Pipeline by Route of Administration, 2016

Nanotherapeutics, Inc. - Pipeline by Molecule Type, 2016

Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll